EP2528433A1 - Solution de fixation pour des cellules biologiques - Google Patents
Solution de fixation pour des cellules biologiquesInfo
- Publication number
- EP2528433A1 EP2528433A1 EP11704659A EP11704659A EP2528433A1 EP 2528433 A1 EP2528433 A1 EP 2528433A1 EP 11704659 A EP11704659 A EP 11704659A EP 11704659 A EP11704659 A EP 11704659A EP 2528433 A1 EP2528433 A1 EP 2528433A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- fixing solution
- cells
- alcohol
- volume
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 44
- 210000004027 cell Anatomy 0.000 claims abstract description 39
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 150000002576 ketones Chemical class 0.000 claims abstract description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 4
- 210000002421 cell wall Anatomy 0.000 claims abstract description 4
- 238000000338 in vitro Methods 0.000 claims abstract description 4
- 230000003204 osmotic effect Effects 0.000 claims abstract description 4
- 230000035939 shock Effects 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 55
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- 230000002380 cytological effect Effects 0.000 claims description 8
- 239000002504 physiological saline solution Substances 0.000 claims description 7
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229960004279 formaldehyde Drugs 0.000 abstract description 19
- 235000019256 formaldehyde Nutrition 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 description 20
- 229960004756 ethanol Drugs 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100001223 noncarcinogenic Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 210000004912 pericardial fluid Anatomy 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1050536A FR2955458B1 (fr) | 2010-01-27 | 2010-01-27 | Solution de fixation pour des cellules biologiques |
| PCT/FR2011/050101 WO2011092414A1 (fr) | 2010-01-27 | 2011-01-20 | Solution de fixation pour des cellules biologiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2528433A1 true EP2528433A1 (fr) | 2012-12-05 |
Family
ID=42312789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP11704659A Withdrawn EP2528433A1 (fr) | 2010-01-27 | 2011-01-20 | Solution de fixation pour des cellules biologiques |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130059330A1 (zh) |
| EP (1) | EP2528433A1 (zh) |
| JP (1) | JP2013518087A (zh) |
| KR (1) | KR20120128131A (zh) |
| CN (1) | CN102791124B (zh) |
| FR (1) | FR2955458B1 (zh) |
| RU (1) | RU2551570C2 (zh) |
| WO (1) | WO2011092414A1 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014151437A1 (en) * | 2013-03-15 | 2014-09-25 | Creatv Microtech, Inc. | Urine preservative reagent for microfiltration |
| CN106706395B (zh) * | 2016-12-08 | 2021-03-02 | 横琴宏恩医疗科技有限公司 | 一种环保固定液 |
| CN111972396A (zh) * | 2019-05-21 | 2020-11-24 | 威海威高医用材料有限公司 | 宫颈脱落细胞保存液及制备方法和细胞保存方法 |
| CN112504793B (zh) * | 2020-10-14 | 2021-10-01 | 核工业总医院 | 用于渗透和固定血细胞的试剂及分析方法 |
| CN113068683B (zh) * | 2021-03-03 | 2022-04-01 | 北京诚智光辉科技有限公司 | 一种液基细胞检查用细胞保存液及其制备方法 |
| CN114208812A (zh) * | 2021-12-22 | 2022-03-22 | 桂林优利特医疗电子有限公司 | 一种液基细胞保存液 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857300A (en) * | 1987-07-27 | 1989-08-15 | Cytocorp, Inc. | Cytological and histological fixative formulation and methods for using same |
| DE69917779T2 (de) * | 1998-06-30 | 2005-06-16 | Lamina, Inc. | Zytologische und histologische fixier-zusammensetzung und verfahren zur verwendung |
| CN1136446C (zh) * | 1998-07-07 | 2004-01-28 | 拉敏纳公司 | 用于混合和加工标本样品的改进方法 |
| RU2194279C2 (ru) * | 1998-12-28 | 2002-12-10 | Новосибирский медицинский институт | Способ цитоморфологического анализа клеточных культур |
| JP4149897B2 (ja) * | 2002-11-07 | 2008-09-17 | 学校法人 聖マリアンナ医科大学 | 気管移植片の調製方法および気管移植片 |
| JP2005211055A (ja) * | 2004-02-02 | 2005-08-11 | Osaka Prefecture | 固定液 |
| UA76372C2 (en) * | 2005-02-01 | 2006-07-17 | Inst Oncology Acad Med Sci Ua | Method for producing cytological preparation of dendritic cells |
-
2010
- 2010-01-27 FR FR1050536A patent/FR2955458B1/fr not_active Expired - Fee Related
-
2011
- 2011-01-20 WO PCT/FR2011/050101 patent/WO2011092414A1/fr active Application Filing
- 2011-01-20 EP EP11704659A patent/EP2528433A1/fr not_active Withdrawn
- 2011-01-20 US US13/575,325 patent/US20130059330A1/en not_active Abandoned
- 2011-01-20 JP JP2012550492A patent/JP2013518087A/ja active Pending
- 2011-01-20 CN CN201180013370.3A patent/CN102791124B/zh not_active Expired - Fee Related
- 2011-01-20 RU RU2012136482/13A patent/RU2551570C2/ru not_active IP Right Cessation
- 2011-01-20 KR KR1020127021833A patent/KR20120128131A/ko not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2011092414A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013518087A (ja) | 2013-05-20 |
| KR20120128131A (ko) | 2012-11-26 |
| FR2955458B1 (fr) | 2014-09-05 |
| RU2012136482A (ru) | 2014-03-10 |
| CN102791124B (zh) | 2014-12-03 |
| FR2955458A1 (fr) | 2011-07-29 |
| US20130059330A1 (en) | 2013-03-07 |
| RU2551570C2 (ru) | 2015-05-27 |
| WO2011092414A1 (fr) | 2011-08-04 |
| CN102791124A (zh) | 2012-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011092414A1 (fr) | Solution de fixation pour des cellules biologiques | |
| US10539488B2 (en) | Sample fixation and stabilisation | |
| CN111372451B (zh) | 用于胞外囊泡的溶血和凝血调节以及稳定化的组合物 | |
| Hosgood et al. | A comparison of hypothermic machine perfusion versus static cold storage in an experimental model of renal ischemia reperfusion injury | |
| Wang et al. | Physiological responses and changes in gene expression in the large yellow croaker Larimichthys crocea following exposure to hypoxia | |
| Kasztan et al. | Long-term endothelin-A receptor antagonism provides robust renal protection in humanized sickle cell disease mice | |
| Abe et al. | Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia–reperfusion injury | |
| ES2649572T3 (es) | Conservación de ácidos nucleicos fuera de las células | |
| JP2014517273A (ja) | 生物学的試料の固定および保存のための固定液 | |
| US20230133626A1 (en) | Storage container for cell-containing solution and storage solution | |
| CN106706395B (zh) | 一种环保固定液 | |
| Zee et al. | Dimethylacetamide can be used as an alternative to glycerol for the successful cryopreservation of koala (Phascolarctos cinereus) spermatozoa | |
| Durant et al. | Evidence that Rh proteins in the anal papillae of the freshwater mosquito Aedes aegypti are involved in the regulation of acid–base balance in elevated salt and ammonia environments | |
| La Manna et al. | An in vivo autotransplant model of renal preservation: cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury | |
| Wang et al. | Exposure to diclofenac alters thyroid hormone levels and transcription of genes involved in the hypothalamic–pituitary–thyroid axis in zebrafish embryos/larvae | |
| Emerson et al. | Preservation of red blood cells in the American alligator (Alligator mississippiensis) over time and in two different anticoagulants | |
| Yamaki et al. | Use of hypertonic solutions for liver preservation in rats | |
| Hanker et al. | Medusa cells: Cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes | |
| Kim et al. | Application of phosphoenolpyruvate into canine red blood cell cryopreservation with hydroxyethyl starch | |
| Amin et al. | The amelorative effect of L-arginin and omega-3 fatty acid against sodium valproate induced hepatotoxicity | |
| CN117858940A (zh) | 细胞含有液用保存液和细胞含有液用保存容器 | |
| RU2370033C1 (ru) | Синтетическая среда для хранения спермы хряков в охлажденном состоянии | |
| da Silva et al. | Criopreservation of Pacu sperm (Piaractus mesopotamicus, Holmberg, 1887) | |
| Shahnazi et al. | Study of protoscolicidal effects of hypertonic glucose on protoscolices of hydatid cyst at different concentrations and exposure times | |
| Young-Min et al. | Clinical Observations on 12 Children with Alport Syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20120727 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20160802 |